Status:
UNKNOWN
Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System
Lead Sponsor:
Fable Biyoteknoloji San ve Tic A.S
Conditions:
Covid19
Eligibility:
All Genders
12-95 years
Phase:
NA
Brief Summary
The aim of this research is to use the Multi-Spectral method to measure the biomolecular fingerprint of the virus directly instead of the virus's RNA (RT-PCR) or the body's immune response (antibody) ...
Detailed Description
The primary purpose of this study is to test whether artificial intelligence (AI) will identify existing SARS-COV-2 in nasopharyngeal swab samples using multi-spectral screening technology.. Multi sp...
Eligibility Criteria
Inclusion
- All people who applied to hospitals with suspicion of COVID-19
Exclusion
- Person who cannot give nasopharyngeal samples
Key Trial Info
Start Date :
February 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2021
Estimated Enrollment :
4400 Patients enrolled
Trial Details
Trial ID
NCT04860895
Start Date
February 11 2021
End Date
May 15 2021
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sancaktepe Şehit Prof.Dr. İlhan Varank Training and Research Hospital
Sancaktepe, Istanbul, Turkey (Türkiye), 34785